Veterinary Biologics Market, Global Outlook and Forecast 2023-2029

Report ID: MMG175136 | Category: Pharma & Healthcare | Pages: 124 | Format: PDF | Published Date: August 16,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Veterinary biologics are vaccines, antigens, antitoxins and other preparations made from living organisms (or genetically engineered) and intended for use in diagnosing, treating, or immunizing animals. Unlike some pharmaceutical products, such as antibiotics, most biologics leave no residues in animals.
This report aims to provide a comprehensive presentation of the global market for Veterinary Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Biologics. This report contains market size and forecasts of Veterinary Biologics in global, including the following market information:
Global Veterinary Biologics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Veterinary Biologics Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Veterinary Biologics companies in 2022 (%)
The global Veterinary Biologics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Vaccines Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Veterinary Biologics include Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio and DHN, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Veterinary Biologics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Veterinary Biologics Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Veterinary Biologics Market Segment Percentages, by Type, 2022 (%)
    Vaccines
    Monoclonal Antibodies
Global Veterinary Biologics Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Veterinary Biologics Market Segment Percentages, by Application, 2022 (%)
    Llivestock
    Equine
    Other
Global Veterinary Biologics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Veterinary Biologics Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Veterinary Biologics revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Veterinary Biologics revenues share in global market, 2022 (%)
Key companies Veterinary Biologics sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Veterinary Biologics sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Merck
    Zoetis
    Boehringer Ingelheim
    Ceva
    CAHIC
    HVRI
    Ringpu Biology
    Yebio
    DHN
    WINSUN
    Elanco/Eli Lilly
    Virbac
    Jinyu Bio-Technology
    ChengDu Tecbond
    CAVAC
    Kyoto Biken
    FATRO
    Vaksindo
    Bio-Labs
    Avimex Animal
Outline of Major Chapters:
Chapter 1: Introduces the definition of Veterinary Biologics, market overview.
Chapter 2: Global Veterinary Biologics market size in revenue and volume.
Chapter 3: Detailed analysis of Veterinary Biologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Veterinary Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Veterinary Biologics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Veterinary Biologics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Veterinary Biologics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Veterinary Biologics Overall Market Size
    2.1 Global Veterinary Biologics Market Size: 2022 VS 2029
    2.2 Global Veterinary Biologics Revenue, Prospects & Forecasts: 2018-2029
    2.3 Global Veterinary Biologics Sales: 2018-2029
3 Company Landscape
    3.1 Top Veterinary Biologics Players in Global Market
    3.2 Top Global Veterinary Biologics Companies Ranked by Revenue
    3.3 Global Veterinary Biologics Revenue by Companies
    3.4 Global Veterinary Biologics Sales by Companies
    3.5 Global Veterinary Biologics Price by Manufacturer (2018-2023)
    3.6 Top 3 and Top 5 Veterinary Biologics Companies in Global Market, by Revenue in 2022
    3.7 Global Manufacturers Veterinary Biologics Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Veterinary Biologics Players in Global Market
        3.8.1 List of Global Tier 1 Veterinary Biologics Companies
        3.8.2 List of Global Tier 2 and Tier 3 Veterinary Biologics Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Veterinary Biologics Market Size Markets, 2022 & 2029
        4.1.2 Vaccines
        4.1.3 Monoclonal Antibodies
    4.2 By Type - Global Veterinary Biologics Revenue & Forecasts
        4.2.1 By Type - Global Veterinary Biologics Revenue, 2018-2023
        4.2.2 By Type - Global Veterinary Biologics Revenue, 2024-2029
        4.2.3 By Type - Global Veterinary Biologics Revenue Market Share, 2018-2029
    4.3 By Type - Global Veterinary Biologics Sales & Forecasts
        4.3.1 By Type - Global Veterinary Biologics Sales, 2018-2023
        4.3.2 By Type - Global Veterinary Biologics Sales, 2024-2029
        4.3.3 By Type - Global Veterinary Biologics Sales Market Share, 2018-2029
    4.4 By Type - Global Veterinary Biologics Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Veterinary Biologics Market Size, 2022 & 2029
        5.1.2 Llivestock
        5.1.3 Equine
        5.1.4 Other
    5.2 By Application - Global Veterinary Biologics Revenue & Forecasts
        5.2.1 By Application - Global Veterinary Biologics Revenue, 2018-2023
        5.2.2 By Application - Global Veterinary Biologics Revenue, 2024-2029
        5.2.3 By Application - Global Veterinary Biologics Revenue Market Share, 2018-2029
    5.3 By Application - Global Veterinary Biologics Sales & Forecasts
        5.3.1 By Application - Global Veterinary Biologics Sales, 2018-2023
        5.3.2 By Application - Global Veterinary Biologics Sales, 2024-2029
        5.3.3 By Application - Global Veterinary Biologics Sales Market Share, 2018-2029
    5.4 By Application - Global Veterinary Biologics Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
    6.1 By Region - Global Veterinary Biologics Market Size, 2022 & 2029
    6.2 By Region - Global Veterinary Biologics Revenue & Forecasts
        6.2.1 By Region - Global Veterinary Biologics Revenue, 2018-2023
        6.2.2 By Region - Global Veterinary Biologics Revenue, 2024-2029
        6.2.3 By Region - Global Veterinary Biologics Revenue Market Share, 2018-2029
    6.3 By Region - Global Veterinary Biologics Sales & Forecasts
        6.3.1 By Region - Global Veterinary Biologics Sales, 2018-2023
        6.3.2 By Region - Global Veterinary Biologics Sales, 2024-2029
        6.3.3 By Region - Global Veterinary Biologics Sales Market Share, 2018-2029
    6.4 North America
        6.4.1 By Country - North America Veterinary Biologics Revenue, 2018-2029
        6.4.2 By Country - North America Veterinary Biologics Sales, 2018-2029
        6.4.3 US Veterinary Biologics Market Size, 2018-2029
        6.4.4 Canada Veterinary Biologics Market Size, 2018-2029
        6.4.5 Mexico Veterinary Biologics Market Size, 2018-2029
    6.5 Europe
        6.5.1 By Country - Europe Veterinary Biologics Revenue, 2018-2029
        6.5.2 By Country - Europe Veterinary Biologics Sales, 2018-2029
        6.5.3 Germany Veterinary Biologics Market Size, 2018-2029
        6.5.4 France Veterinary Biologics Market Size, 2018-2029
        6.5.5 U.K. Veterinary Biologics Market Size, 2018-2029
        6.5.6 Italy Veterinary Biologics Market Size, 2018-2029
        6.5.7 Russia Veterinary Biologics Market Size, 2018-2029
        6.5.8 Nordic Countries Veterinary Biologics Market Size, 2018-2029
        6.5.9 Benelux Veterinary Biologics Market Size, 2018-2029
    6.6 Asia
        6.6.1 By Region - Asia Veterinary Biologics Revenue, 2018-2029
        6.6.2 By Region - Asia Veterinary Biologics Sales, 2018-2029
        6.6.3 China Veterinary Biologics Market Size, 2018-2029
        6.6.4 Japan Veterinary Biologics Market Size, 2018-2029
        6.6.5 South Korea Veterinary Biologics Market Size, 2018-2029
        6.6.6 Southeast Asia Veterinary Biologics Market Size, 2018-2029
        6.6.7 India Veterinary Biologics Market Size, 2018-2029
    6.7 South America
        6.7.1 By Country - South America Veterinary Biologics Revenue, 2018-2029
        6.7.2 By Country - South America Veterinary Biologics Sales, 2018-2029
        6.7.3 Brazil Veterinary Biologics Market Size, 2018-2029
        6.7.4 Argentina Veterinary Biologics Market Size, 2018-2029
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Veterinary Biologics Revenue, 2018-2029
        6.8.2 By Country - Middle East & Africa Veterinary Biologics Sales, 2018-2029
        6.8.3 Turkey Veterinary Biologics Market Size, 2018-2029
        6.8.4 Israel Veterinary Biologics Market Size, 2018-2029
        6.8.5 Saudi Arabia Veterinary Biologics Market Size, 2018-2029
        6.8.6 UAE Veterinary Biologics Market Size, 2018-2029
7 Manufacturers & Brands Profiles
    7.1 Merck
        7.1.1 Merck Company Summary
        7.1.2 Merck Business Overview
        7.1.3 Merck Veterinary Biologics Major Product Offerings
        7.1.4 Merck Veterinary Biologics Sales and Revenue in Global (2018-2023)
        7.1.5 Merck Key News & Latest Developments
    7.2 Zoetis
        7.2.1 Zoetis Company Summary
        7.2.2 Zoetis Business Overview
        7.2.3 Zoetis Veterinary Biologics Major Product Offerings
        7.2.4 Zoetis Veterinary Biologics Sales and Revenue in Global (2018-2023)
        7.2.5 Zoetis Key News & Latest Developments
    7.3 Boehringer Ingelheim
        7.3.1 Boehringer Ingelheim Company Summary
        7.3.2 Boehringer Ingelheim Business Overview
        7.3.3 Boehringer Ingelheim Veterinary Biologics Major Product Offerings
        7.3.4 Boehringer Ingelheim Veterinary Biologics Sales and Revenue in Global (2018-2023)
        7.3.5 Boehringer Ingelheim Key News & Latest Developments
    7.4 Ceva
        7.4.1 Ceva Company Summary
        7.4.2 Ceva Business Overview
        7.4.3 Ceva Veterinary Biologics Major Product Offerings
        7.4.4 Ceva Veterinary Biologics Sales and Revenue in Global (2018-2023)
        7.4.5 Ceva Key News & Latest Developments
    7.5 CAHIC
        7.5.1 CAHIC Company Summary
        7.5.2 CAHIC Business Overview
        7.5.3 CAHIC Veterinary Biologics Major Product Offerings
        7.5.4 CAHIC Veterinary Biologics Sales and Revenue in Global (2018-2023)
        7.5.5 CAHIC Key News & Latest Developments
    7.6 HVRI
        7.6.1 HVRI Company Summary
        7.6.2 HVRI Business Overview
        7.6.3 HVRI Veterinary Biologics Major Product Offerings
        7.6.4 HVRI Veterinary Biologics Sales and Revenue in Global (2018-2023)
        7.6.5 HVRI Key News & Latest Developments
    7.7 Ringpu Biology
        7.7.1 Ringpu Biology Company Summary
        7.7.2 Ringpu Biology Business Overview
        7.7.3 Ringpu Biology Veterinary Biologics Major Product Offerings
        7.7.4 Ringpu Biology Veterinary Biologics Sales and Revenue in Global (2018-2023)
        7.7.5 Ringpu Biology Key News & Latest Developments
    7.8 Yebio
        7.8.1 Yebio Company Summary
        7.8.2 Yebio Business Overview
        7.8.3 Yebio Veterinary Biologics Major Product Offerings
        7.8.4 Yebio Veterinary Biologics Sales and Revenue in Global (2018-2023)
        7.8.5 Yebio Key News & Latest Developments
    7.9 DHN
        7.9.1 DHN Company Summary
        7.9.2 DHN Business Overview
        7.9.3 DHN Veterinary Biologics Major Product Offerings
        7.9.4 DHN Veterinary Biologics Sales and Revenue in Global (2018-2023)
        7.9.5 DHN Key News & Latest Developments
    7.10 WINSUN
        7.10.1 WINSUN Company Summary
        7.10.2 WINSUN Business Overview
        7.10.3 WINSUN Veterinary Biologics Major Product Offerings
        7.10.4 WINSUN Veterinary Biologics Sales and Revenue in Global (2018-2023)
        7.10.5 WINSUN Key News & Latest Developments
    7.11 Elanco/Eli Lilly
        7.11.1 Elanco/Eli Lilly Company Summary
        7.11.2 Elanco/Eli Lilly Veterinary Biologics Business Overview
        7.11.3 Elanco/Eli Lilly Veterinary Biologics Major Product Offerings
        7.11.4 Elanco/Eli Lilly Veterinary Biologics Sales and Revenue in Global (2018-2023)
        7.11.5 Elanco/Eli Lilly Key News & Latest Developments
    7.12 Virbac
        7.12.1 Virbac Company Summary
        7.12.2 Virbac Veterinary Biologics Business Overview
        7.12.3 Virbac Veterinary Biologics Major Product Offerings
        7.12.4 Virbac Veterinary Biologics Sales and Revenue in Global (2018-2023)
        7.12.5 Virbac Key News & Latest Developments
    7.13 Jinyu Bio-Technology
        7.13.1 Jinyu Bio-Technology Company Summary
        7.13.2 Jinyu Bio-Technology Veterinary Biologics Business Overview
        7.13.3 Jinyu Bio-Technology Veterinary Biologics Major Product Offerings
        7.13.4 Jinyu Bio-Technology Veterinary Biologics Sales and Revenue in Global (2018-2023)
        7.13.5 Jinyu Bio-Technology Key News & Latest Developments
    7.14 ChengDu Tecbond
        7.14.1 ChengDu Tecbond Company Summary
        7.14.2 ChengDu Tecbond Business Overview
        7.14.3 ChengDu Tecbond Veterinary Biologics Major Product Offerings
        7.14.4 ChengDu Tecbond Veterinary Biologics Sales and Revenue in Global (2018-2023)
        7.14.5 ChengDu Tecbond Key News & Latest Developments
    7.15 CAVAC
        7.15.1 CAVAC Company Summary
        7.15.2 CAVAC Business Overview
        7.15.3 CAVAC Veterinary Biologics Major Product Offerings
        7.15.4 CAVAC Veterinary Biologics Sales and Revenue in Global (2018-2023)
        7.15.5 CAVAC Key News & Latest Developments
    7.16 Kyoto Biken
        7.16.1 Kyoto Biken Company Summary
        7.16.2 Kyoto Biken Business Overview
        7.16.3 Kyoto Biken Veterinary Biologics Major Product Offerings
        7.16.4 Kyoto Biken Veterinary Biologics Sales and Revenue in Global (2018-2023)
        7.16.5 Kyoto Biken Key News & Latest Developments
    7.17 FATRO
        7.17.1 FATRO Company Summary
        7.17.2 FATRO Business Overview
        7.17.3 FATRO Veterinary Biologics Major Product Offerings
        7.17.4 FATRO Veterinary Biologics Sales and Revenue in Global (2018-2023)
        7.17.5 FATRO Key News & Latest Developments
    7.18 Vaksindo
        7.18.1 Vaksindo Company Summary
        7.18.2 Vaksindo Business Overview
        7.18.3 Vaksindo Veterinary Biologics Major Product Offerings
        7.18.4 Vaksindo Veterinary Biologics Sales and Revenue in Global (2018-2023)
        7.18.5 Vaksindo Key News & Latest Developments
    7.19 Bio-Labs
        7.19.1 Bio-Labs Company Summary
        7.19.2 Bio-Labs Business Overview
        7.19.3 Bio-Labs Veterinary Biologics Major Product Offerings
        7.19.4 Bio-Labs Veterinary Biologics Sales and Revenue in Global (2018-2023)
        7.19.5 Bio-Labs Key News & Latest Developments
    7.20 Avimex Animal
        7.20.1 Avimex Animal Company Summary
        7.20.2 Avimex Animal Business Overview
        7.20.3 Avimex Animal Veterinary Biologics Major Product Offerings
        7.20.4 Avimex Animal Veterinary Biologics Sales and Revenue in Global (2018-2023)
        7.20.5 Avimex Animal Key News & Latest Developments
8 Global Veterinary Biologics Production Capacity, Analysis
    8.1 Global Veterinary Biologics Production Capacity, 2018-2029
    8.2 Veterinary Biologics Production Capacity of Key Manufacturers in Global Market
    8.3 Global Veterinary Biologics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Veterinary Biologics Supply Chain Analysis
    10.1 Veterinary Biologics Industry Value Chain
    10.2 Veterinary Biologics Upstream Market
    10.3 Veterinary Biologics Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Veterinary Biologics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Veterinary Biologics Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?